Patents
Literature
3 results about "EGF Receptors" patented technology
Efficacy Topic
Property
Owner
Technical Advancement
Application Domain
Technology Topic
Technology Field Word
Patent Country/Region
Patent Type
Patent Status
Application Year
Inventor
Epidermal growth factor derivative and use of same
PCT designated stageWO2026132636A1Peptide/protein ingredientsAntineoplastic agentsDiseaseCancer research
The present invention relates to an epidermal growth factor derivative called mdEGF comprising or consisting of the amino acid sequence: NSDSECPLSHDGYCLHDGVCGYTEAGDKYACDCVVGYIGERCQYRDLKWWELR. The present invention also relates to the use of the epidermal growth factor derivative mdEGF in preventing and / or treating a disease related to increased activity of EGF receptor (EGFR), namely, cancer.
Owner:UNIV DE GIRONA +1
Alkylamido compounds and uses thereof
Disclosed herein are compounds that may be specific to PPAR and / or EGF receptors, and methods of making and using same.
Owner:NOGRA PHARMA LTD
Combination of HB-EGF inhibitor and corticosteroid agent for treating nephropathy associated with activation of HB-EGF / EGFR pathway
The present invention relates to a combination of a corticosteroid agent and a heparin-binding epidermal growth factor-like growth factor (HB-EGF) inhibitor for use in the treatment of nephropathy associated with the activation of the HB-EGF / EGF receptor pathway.
Owner:COMMISSARIAT A LENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES +1